Internal Medicine, Endocrinology, Diabetes, & Metabolism · Munster, IN
NPI
1558357228
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
8230 Calumet Ave
Munster, IN, 46321
Phone (219) 836-9600
Groups this clinician bills Medicare through
Medicare paid, 2024
$186K
3,480 services
Medicare patients, 2024
573
Average age 72
Drug cost, 2024
$3.3M
8,132 prescriptions
Company payments, 2025
$1,072
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nabeel Jabri was code 99231 (hospital e&m - subsequent), 1,202 times for 134 patients. In total Nabeel Jabri billed 3,480 services in 22 codes, and Medicare paid $186K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99231 Hospital E&M - Subsequent | Facility | 1,202 | 134 | $41.01 | $49K |
| 99214 Office E&M - Established | Office | 530 | 278 | $86.14 | $46K |
| 99213 Office E&M - Established | Office | 442 | 247 | $66.80 | $30K |
| 95251 Test - Miscellaneous | Office | 388 | 147 | $25.51 | $9,897 |
| 82947 Clinical Chemistry | Office | 335 | 159 | $3.76 | $1,259 |
| 99232 Hospital E&M - Subsequent | Facility | 207 | 125 | $63.99 | $13K |
| 99204 Office E&M - New | Office | 58 | 58 | $126.88 | $7,359 |
| 99222 Hospital E&M - Initial | Facility | 57 | 50 | $107.33 | $6,118 |
| 99223 Hospital E&M - Initial | Facility | 51 | 49 | $139.25 | $7,102 |
| 99215 Office E&M - Established | Office | 46 | 40 | $110.32 | $5,075 |
| 95250 Test - Miscellaneous | Office | 44 | 38 | $107.86 | $4,746 |
| 99233 Hospital E&M - Subsequent | Facility | 43 | 34 | $94.73 | $4,073 |
| 96372 Injection Administration | Office | 28 | 24 | $10.31 | $289 |
| 99203 Office E&M - New | Office | 14 | 14 | $80.53 | $1,127 |
By year: 2022 $224K for 3,389 services; 2023 $226K for 3,353 services; 2024 $186K for 3,480 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 335 | 159 | $3.76 | $1,259 |
Medicare prescription drug claims, 2024
In 2024, the drug Nabeel Jabri prescribed most often to Medicare patients was Ozempic (Semaglutide), with 527 prescriptions and refills. In total Nabeel Jabri wrote 8,132 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 527 | 829 | 123 | $794K |
| Metformin Hcl Generic | 473 | 1,231 | 152 | $3,386 |
| Jardiance Empagliflozin | 451 | 853 | 122 | $494K |
| Farxiga Dapagliflozin Propanediol | 429 | 776 | 103 | $420K |
| Levothyroxine Sodium Generic | 411 | 986 | 98 | $4,944 |
| Glipizide Er Glipizide | 406 | 1,106 | 138 | $4,932 |
| Acarbose Generic | 343 | 715 | 99 | $11K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 265 | 596 | 103 | $27K |
| Lisinopril Generic | 255 | 710 | 81 | $1,548 |
| Atorvastatin Calcium Generic | 225 | 608 | 74 | $1,807 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 218 | 458 | 75 | $31K |
| Trulicity Dulaglutide | 201 | 307 | 46 | $301K |
| Synthroid Levothyroxine Sodium | 150 | 400 | 41 | $14K |
| Simvastatin Generic | 140 | 382 | 52 | $1,072 |
| Unithroid Levothyroxine Sodium | 136 | 386 | 38 | $5,755 |
Brand drugs: 3,680 claims; generic drugs: 3,910 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nabeel Jabri $1,072 ($1,072 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $206.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $206 |
| Lilly USA, LLC LLY | 14 | $202 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 13 | $155 |
| Insulet Corporation PODD | 2 | $91.43 |
| Amgen Inc. AMGN | 4 | $86.26 |
| Beta Bionics, Inc. BBNX | 3 | $45.15 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $37.85 |
| Novo Nordisk Inc NVO | 2 | $35.64 |
| Xeris Pharmaceuticals, Inc. | 2 | $33.48 |
| Recordati_rare_diseases_inc. | 2 | $31.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.